LMNB1 reduction is a potential therapeutic strategy in a mouse model of autosomal dominant leukodystrophy
- DOI
- 10.1172/jci.insight.207889
- Published
- 2026-08-11
- Container
- JCI Insight
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci.insight.207889,
title = {LMNB1 reduction is a potential therapeutic strategy in a mouse model of autosomal dominant leukodystrophy},
author = {Nathan Herdman and Kaveh Moradi and Bruce Nmezi and Anushe Munir and Krizchelle A. Magtoto and Fang Liu and Mara Sullivan and Xuemei Zeng and Thomas K. Karikari and Quasar S. Padiath},
year = {2026},
journal = {JCI Insight},
doi = {10.1172/jci.insight.207889},
url = {https://doi.org/10.1172/jci.insight.207889}
}RIS
TY - JOUR TI - LMNB1 reduction is a potential therapeutic strategy in a mouse model of autosomal dominant leukodystrophy AU - Nathan Herdman AU - Kaveh Moradi AU - Bruce Nmezi AU - Anushe Munir AU - Krizchelle A. Magtoto AU - Fang Liu AU - Mara Sullivan AU - Xuemei Zeng AU - Thomas K. Karikari AU - Quasar S. Padiath PY - 2026 JO - JCI Insight DO - 10.1172/jci.insight.207889 UR - https://doi.org/10.1172/jci.insight.207889 ER -
APA
Herdman, N., Moradi, K., Nmezi, B., Munir, A., Magtoto, K. A., Liu, F., Sullivan, M., Zeng, X., Karikari, T. K., & Padiath, Q. S. (2026). LMNB1 reduction is a potential therapeutic strategy in a mouse model of autosomal dominant leukodystrophy. JCI Insight. https://doi.org/10.1172/jci.insight.207889
Source records
- crossref · retrieved 2026-09-26T05:42:46.051Z